B-LYMPHOCYTE ANTIGEN CD19

Investigational

Approval Year

Substance Class	Protein
Protein Sub Type
Sequence Type	COMPLETE
Record UNII	IYZ9TI08W3
Record Status	`Validated (UNII)`
Record Version

Show entries

Name

Type

Language

B-LYMPHOCYTE SURFACE ANTIGEN B4

Preferred Name

English

B-LYMPHOCYTE ANTIGEN CD19

Common Name

English

CD19

Common Name

English

CD-19

Common Name

English

T-CELL SURFACE ANTIGEN LEU-12

Common Name

English

Showing 1 to 5 of 6 entries

Previous1 2Next

Show entries

Code System

Code

Type

Description

FDA UNII

IYZ9TI08W3

PRIMARY

UNIPROT

P15391

PRIMARY

Showing 1 to 2 of 2 entries

Previous1Next

Subunit 0

Show entries

From	To
1_19	1_78
1_181	1_242

Showing 1 to 2 of 2 entries

Previous1Next

Glycosylation Type

HUMAN

Show entries

Glycosylation Link Type	Site
N	1_67
N	1_106
N	1_119
N	1_162
N	1_246

Showing 1 to 5 of 5 entries

Previous1Next

Show entries

Related Record

Type

Details


					E4ET672BAP

Budoprutug

LIGAND->TARGET

Interaction Type:

IN-VITRO, IN-VIVO

Amount:


					LN7HYS3NX9

Nespecabtagene Autoleucel

CYTOTOXIC T-CELL->TARGET

Amount:


					0LPG0J327L

DENINTUZUMAB

LIGAND->TARGET


					H5324S1M7H

DENINTUZUMAB MAFODOTIN

CONJUGATED TOXIN->TARGET

Amount:


					BK3WC9ZP7A

Zeripatamig

INHIBITOR -> TARGET

Amount:

Showing 1 to 5 of 22 entries

Previous1 2 3 4 5Next

Structural Modifications

Show entries

Modification Type	Location Site	Location Type	Residue Modified	Extent	Fragment Name	Fragment Approval
AMINO ACID SUBSTITUTION	[1_329] [1_359] [1_390] [1_420] [1_481]				TYROSINE O-PHOSPHATE	2R86C98KDX
AMINO ACID SUBSTITUTION	[1_208]			Amount: MOLE PER SUBUNIT [<2] (limits)	DEXFOSFOSERINE	VI4F0K069V

Showing 1 to 2 of 2 entries

Previous1Next

Show entries

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT	CHEMICAL

Showing 1 to 1 of 1 entries

Previous1Next